Literature DB >> 32892542

Stereological and histopathological evaluation of the effect of Thymoquinone on peridural fibrosis following laminectomy in rats

Dursun Türköz1, Aytaç Türköz1, Mehmet Emin Önger2, Enis Kuruoğlu1.   

Abstract

Background/aim: This study’s aim was to investigate the effects of thymoquinone, which is the essential bioactive component of the volatile oil of Nigella sativa on the peridural fibrosis in rats following laminectomy. Materials and methods: Twenty female Wistar Albino rats were used in our study. The rats were randomly divided into 2 groups: Sham and Surgery + Thymoquinone. Both groups underwent laminectomy at L1 under general anesthesia. The Sham group was not subjected to any drug application. The 2nd group was treated with intraperitoneal 10-mg/kg thymoquinone once per day for a period of 28 days, following the same surgical procedure. All of the group specimens were sacrificed after 4 weeks, and the laminectomy area was examined in terms of new bone volume, capillary volume, and fibrosis volume using stereological approaches.
Results: Statistically significant differences were found between the Sham and Surgery + Thymoquinone groups in terms of new bone volume (P = 0.01), capillary volume (P = 0.01), and fibrosis volume (P < 0.001). It was noted that Thymoquinone caused a significant increase in new bone volume, vascular volume and, a significant decrease in fibrosis volume.
Conclusion: The results of our study indicate that thymoquinone is effective in decreasing peridural fibrosis when applied to a laminectomy model. This work is licensed under a Creative Commons Attribution 4.0 International License.

Entities:  

Keywords:  Laminectomy; peridural fibrosis; thymoquinone

Year:  2021        PMID: 32892542      PMCID: PMC7991881          DOI: 10.3906/sag-2006-147

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  37 in total

1.  Repeat surgery after disc excision.

Authors:  J Cauchoix; C Ficat; B Girard
Journal:  Spine (Phila Pa 1976)       Date:  1978-09       Impact factor: 3.468

2.  Clinical outcome of surgical treatment of failed back surgery syndrome.

Authors:  Ghassan Skaf; Carmel Bouclaous; Ali Alaraj; Roukoz Chamoun
Journal:  Surg Neurol       Date:  2005-12

3.  Neuroprotective effects of thymoquinone against spinal cord ischemia-reperfusion injury by attenuation of inflammation, oxidative stress, and apoptosis.

Authors:  Emre Cemal Gökce; Ramazan Kahveci; Aysun Gökce; Berker Cemil; Nurkan Aksoy; Mustafa Fevzi Sargon; Üçler Kısa; Bülent Erdoğan; Yahya Güvenç; Fatih Alagöz; Ozan Kahveci
Journal:  J Neurosurg Spine       Date:  2016-02-12

4.  Inhibition of 5-lipoxygenase and leukotriene C4 synthase in human blood cells by thymoquinone.

Authors:  Mahmoud Mansour; Susanne Tornhamre
Journal:  J Enzyme Inhib Med Chem       Date:  2004-10       Impact factor: 5.051

Review 5.  Epigenetic role of thymoquinone: impact on cellular mechanism and cancer therapeutics.

Authors:  Md Asaduzzaman Khan; Mousumi Tania; Junjiang Fu
Journal:  Drug Discov Today       Date:  2019-09-18       Impact factor: 7.851

6.  Etiologies of failed back surgery syndrome.

Authors:  Curtis W Slipman; Carl H Shin; Rajeev K Patel; Zacharia Isaac; Chris W Huston; Jason S Lipetz; David A Lenrow; Debra L Braverman; Edward J Vresilovic
Journal:  Pain Med       Date:  2002-09       Impact factor: 3.750

7.  Thymoquinone effectively alleviates lung fibrosis induced by paraquat herbicide through down-regulation of pro-fibrotic genes and inhibition of oxidative stress.

Authors:  Fatemeh Pourgholamhossein; Fariba Sharififar; Rokhsana Rasooli; Leyla Pourgholi; Fatemeh Nakhaeipour; Hojjat Samareh-Fekri; Maryam Iranpour; Ali Mandegary
Journal:  Environ Toxicol Pharmacol       Date:  2016-06-18       Impact factor: 4.860

8.  Failed back surgery syndrome: 5-year follow-up in 102 patients undergoing repeated operation.

Authors:  R B North; J N Campbell; C S James; M K Conover-Walker; H Wang; S Piantadosi; J D Rybock; D M Long
Journal:  Neurosurgery       Date:  1991-05       Impact factor: 4.654

9.  The assessment of new bone formation induced by unfocused extracorporeal shock wave therapy applied on pre-surgical phase of distraction osteogenesis.

Authors:  Erman Senel; Enes Ozkan; Mehmet Cihan Bereket; Mehmet Emin Onger
Journal:  Eur Oral Res       Date:  2019-09-01

Review 10.  Thymoquinone (2-Isoprpyl-5-methyl-1, 4-benzoquinone) as a chemopreventive/anticancer agent: Chemistry and biological effects.

Authors:  Anas Ahmad; Rakesh Kumar Mishra; Akshay Vyawahare; Ajay Kumar; Muneeb U Rehman; Wajhul Qamar; Abdul Quaiyoom Khan; Rehan Khan
Journal:  Saudi Pharm J       Date:  2019-09-25       Impact factor: 4.330

View more
  1 in total

Review 1.  Thymoquinone in Ocular Neurodegeneration: Modulation of Pathological Mechanisms via Multiple Pathways.

Authors:  Nur Musfirah Mahmud; Luminita Paraoan; Nurliza Khaliddin; Tengku Ain Kamalden
Journal:  Front Cell Neurosci       Date:  2022-03-02       Impact factor: 5.505

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.